These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9025848)

  • 1. Prostaglandin E1-induced hyperostosis: clinicopathologic correlations and possible pathogenetic mechanisms.
    Faye-Petersen OM; Johnson WH; Carlo WA; Hedlund GL; Pacifico AD; Blair HC
    Pediatr Pathol Lab Med; 1996; 16(3):489-507. PubMed ID: 9025848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation.
    Woo K; Emery J; Peabody J
    Pediatrics; 1994 Mar; 93(3):417-20. PubMed ID: 8115200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
    Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
    J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plain film and CT observations in prostaglandin-induced bone changes.
    Matzinger MA; Briggs VA; Dunlap HJ; Udjus K; Martin DJ; McDonald P
    Pediatr Radiol; 1992; 22(4):264-6. PubMed ID: 1523047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease.
    Nadroo AM; Shringari S; Garg M; al-Sowailem AM
    J Perinat Med; 2000; 28(6):447-52. PubMed ID: 11155430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
    Fernández MA; Gebara E
    Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: a case report.
    Alan S; Uçar T; Erdeve O; Atasay B; Arsan S; Atalay S
    Turk J Pediatr; 2013; 55(5):543-5. PubMed ID: 24382539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical hyperostosis as a side-effect of prolonged use of prostaglandins.
    Rivero Jiménez N; Bret-Zurita M; García-Guereta Silva L
    Cardiol Young; 2016 Jan; 26(1):149-50. PubMed ID: 26423344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report 701: Prostaglandin E1 (PGE1) periostitis.
    Rowley RF; Lawson JP
    Skeletal Radiol; 1991; 20(8):617-9. PubMed ID: 1776031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
    Kalloghlian AK; Frayha HH; deMoor MM
    Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
    Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
    Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periosteal reaction following prostaglandin E1 therapy.
    Pediatr Radiol; 1990; 20(3):212. PubMed ID: 2352806
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
    Høst A; Halken S; Andersen PE
    Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of prostaglandin-induced cortical hyperostosis in an infant.
    Alpert BS; Jureidini SB; Vanderzalm T
    South Med J; 1984 Aug; 77(8):1039-40. PubMed ID: 6540475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periosteal hyperostosis resulting from prostaglandin therapy.
    Williams JL
    Eur J Radiol; 1986 Aug; 6(3):231-2. PubMed ID: 3769947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side-effects of long-term prostaglandin E(1) treatment in neonates.
    Tálosi G; Katona M; Túri S
    Pediatr Int; 2007 Jun; 49(3):335-40. PubMed ID: 17532831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
    Leonhardt A; Schweer H; Wolf D; Seyberth HW
    Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review.
    Velaphi S; Cilliers A; Beckh-Arnold E; Mokhachane M; Mphahlele R; Pettifor J
    J Perinatol; 2004 Apr; 24(4):263-5. PubMed ID: 15067299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
    Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
    Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.